Yanjan(300658)
Search documents
延江股份(300658) - 关于本次交易采取的保密措施及保密制度的说明
2026-01-18 07:45
在与交易对方开始接洽本次交易事宜之初,公司及其他相关机构就始终采取 严格的保密措施及制度,确保交易有关信息不外泄。公司董事会就在本次交易中 所采取的保密措施及保密制度说明如下: 一、公司在本次交易中严格按照《上市公司重大资产重组管理办法》《上市 公司信息披露管理办法》及《深圳证券交易所创业板股票上市规则》等法律、法 规和规范性法律文件的要求,遵循《厦门延江新材料股份有限公司章程》及内部 管理制度的规定,就本次交易采取了充分必要的保护措施,制定了严格有效的保 密制度。 二、公司高度重视内幕信息管理,按照《上市公司监管指引第 5 号—上市公 司内幕信息知情人登记管理制度》等相关规定,严格控制内幕信息知情人范围, 及时记录商议筹划、论证咨询等阶段的内幕信息知情人及筹划过程,制作交易进 程备忘录。 三、为保证本次交易的相关事宜不被泄露,公司与拟聘请的中介机构分别签 署了保密协议。本公司及各拟聘请中介机构按照相关法律、法规和规范性文件的 要求开展工作,各方参与人员均严格遵守保密协议的规定。 厦门延江新材料股份有限公司董事会 关于本次交易采取的保密措施及保密制度的说明 厦门延江新材料股份有限公司(以下简称"公司"或"上市 ...
延江股份(300658) - 关于本次交易前12个月内购买、出售资产情况的说明
2026-01-18 07:45
厦门延江新材料股份有限公司董事会 关于本次交易前 12 个月内购买、出售资产情况的说明 厦门延江新材料股份有限公司(以下简称"公司")拟通过发行股份及支付 现金方式购买 JIANGQIHE、QIANGYUAN、孙行宇、吴继勇、朱思哲、陈勤、 杨登、唐晓煜、胡天瑜、宁波源路载科技合伙企业(有限合伙)、宁波瀚海乾元 股权投资基金合伙企业(有限合伙)、浙江润禾控股有限公司、宁波微科控股有 限公司、蓉创(淄博)股权投资合伙企业(有限合伙)、宁波英华瀚鼎创业投资 合伙企业(有限合伙)、成都量子聚益创业投资合伙企业(有限合伙)、海宁君 马新材料产业投资合伙企业(有限合伙)、福建劲邦晋新创业投资合伙企业(有 限合伙)、成都励石创业投资合伙企业(有限合伙)、宁波市北仑永辉模具有限 公司、宁波源星雄控股有限公司、克拉玛依云泽集成电路产业投资有限合伙企业、 苏州沃赋睿鑫创业投资合伙企业(有限合伙)、兴森股权投资(广州)合伙企业 (有限合伙)、嘉兴嘉创昊瑞股权投资合伙企业(有限合伙)、宁波蓝郡至达创 业投资中心(有限合伙)、徐州盛芯半导体产业投资基金合伙企业(有限合伙)、 新余森泽并购投资管理合伙企业(有限合伙)合计 28 名股东 ...
延江股份(300658) - 关于暂不召开股东会审议本次交易相关事项的公告
2026-01-18 07:45
厦门延江新材料股份有限公司(以下简称"公司")拟通过发行股份及支付 现金方式购买 JIANGQIHE、QIANGYUAN、孙行宇、吴继勇、朱思哲、陈勤、 杨登、唐晓煜、胡天瑜、宁波源路载科技合伙企业(有限合伙)、宁波瀚海乾元 股权投资基金合伙企业(有限合伙)、浙江润禾控股有限公司、宁波微科控股有 限公司、蓉创(淄博)股权投资合伙企业(有限合伙)、宁波英华瀚鼎创业投资 合伙企业(有限合伙)、成都量子聚益创业投资合伙企业(有限合伙)、海宁君 马新材料产业投资合伙企业(有限合伙)、福建劲邦晋新创业投资合伙企业(有 限合伙)、成都励石创业投资合伙企业(有限合伙)、宁波市北仑永辉模具有限 公司、宁波源星雄控股有限公司、克拉玛依云泽集成电路产业投资有限合伙企业、 苏州沃赋睿鑫创业投资合伙企业(有限合伙)、兴森股权投资(广州)合伙企业 (有限合伙)、嘉兴嘉创昊瑞股权投资合伙企业(有限合伙)、宁波蓝郡至达创 业投资中心(有限合伙)、徐州盛芯半导体产业投资基金合伙企业(有限合伙)、 新余森泽并购投资管理合伙企业(有限合伙)合计 28 名股东合计持有的宁波甬 强科技有限公司(以下简称"标的公司")98.54%股权并募集配套资金( ...
延江股份(300658) - 第四届董事会第十一次会议决议公告
2026-01-18 07:45
一、审议通过《关于公司本次发行股份及支付现金购买资产并募集配套资 金暨关联交易符合相关法律法规的议案》 厦门延江新材料股份有限公司 第四届董事会第十一次会议决议公告 证券代码:300658 证券简称:延江股份 公告编号:2026-003 厦门延江新材料股份有限公司 第四届董事会第十一次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假 记载、误导性陈述或重大遗漏。 2026 年 1 月 16 日,厦门延江新材料股份有限公司第四届董事会第十一次会 议在公司会议室召开,应到董事 8 人,实到董事 8 人。会议采用现场表决与通讯 表决相结合的方式进行。本次会议的召开符合《中华人民共和国公司法》(以下 简称《公司法》)、相关法律法规以及公司章程的规定。 谢继华先生主持本次会议,公司高级管理人员列席了本次会议。本次会议审 议通过了以下事项: 表决结果:5 票通过、0 票反对、0 票弃权。关联董事谢继华、谢继权、谢 淑冬回避表决。 本议案尚需提交公司股东会审议。 公司拟通过发行股份及支付现金的方式购买交易对方 JIANGQI HE、QIANG YUAN、孙行宇、宁波源路载科技合伙企业(有限合 ...
延江股份:1月16日召开董事会会议
Mei Ri Jing Ji Xin Wen· 2026-01-18 07:43
每经AI快讯,延江股份1月18日晚间发布公告称,公司第四届第十一次董事会会议于2026年1月16日在 公司会议室召开。会议审议了《关于公司本次发行股份及支付现金购买资产并募集配套资金暨关联交易 符合相关法律法规的议案》等文件。 (记者 胡玲) 每经头条(nbdtoutiao)——深入委内瑞拉、伊朗、俄乌、加沙,马斯克"星链"成国际冲突标配,4年半 用户激增114倍!SpaceX估值已超5.5万亿元,美国政府是重要支持者 ...
延江股份:筹划收购事项停牌,披露前十股东持股情况
Xin Lang Cai Jing· 2026-01-18 07:43
延江股份公告称,公司正在筹划收购宁波甬强科技有限公司控制权事宜,股票于2026年1月5日开市起停 牌。同时,公司披露股票停牌前一交易日(2025年*月*日)前十大股东和前十大流通股股东持股情况, 谢继华持股72,027,927股、占比21.65%为第一大股东,"延江股份回购专用证券账户"持股4,757,800股; 谢影秋已过世,其5.58%股权由陈子安继承,过户手续仍在办理中。 ...
延江股份:筹划收购资产,股票将于1月19日开市起复牌
Xin Lang Cai Jing· 2026-01-18 07:43
延江股份公告称,公司拟筹划收购宁波甬强科技有限公司控制权事宜,因该交易尚存不确定性,公司股 票自2026年1月5日开市起停牌。1月16日,公司召开第四届董事会第十一次会议,审议通过相关议案。 经申请,公司股票将于1月19日开市起复牌。本次交易涉及的资产审计、评估工作未完成,暂不召开股 东会。交易存在或因内幕交易被查而终止,以及审批结果和时间不确定的风险。 ...
延江股份:筹划购买资产,股票继续停牌
Bei Ke Cai Jing· 2026-01-12 03:01
新京报贝壳财经讯 1月11日,延江股份发布公告称,公司正计划通过发行股份等方式收购资产,并拟同 步募集配套资金,该事项预计可能构成重大资产重组。为保障投资者权益,公司股票已于2026年1月5日 开市起停牌,原计划在2026年1月19日前披露交易方案。公告显示,截至目前,公司及相关各方正积极 推进本次交易的各项工作。由于交易相关事项尚存不确定性,为维护投资者利益,防止公司股价出现异 常波动,依据深圳证券交易所的相关规定,公司股票将继续停牌。 ...
1月12日重要公告一览
Xi Niu Cai Jing· 2026-01-12 02:36
Group 1 - Defu Technology plans to acquire at least 51% of Huiru Technology through cash purchase and capital increase, making Huiru a subsidiary [1] - Huiru Technology specializes in the research, production, and sales of high-performance electrolytic copper foil, including lithium battery copper foil and electronic circuit copper foil [1] Group 2 - Medike's shareholder plans to reduce holdings by no more than 1% of the company's shares, amounting to approximately 410.93 million shares [2] - Huadong Medicine's subsidiary, Daor Biotechnology, has its product DR10624 included in the list of breakthrough therapeutic varieties, targeting severe hypertriglyceridemia [3] Group 3 - Fangsheng Pharmaceutical received a notice of non-compliance from the Hunan Provincial Drug Administration regarding its raw material drug production [4] - Yanjing Co. is planning a major asset restructuring, leading to a temporary suspension of its stock [5] - Xianle Health intends to issue H-shares and apply for listing on the Hong Kong Stock Exchange [6] Group 4 - Huate Gas shareholders plan to collectively reduce their holdings by no more than 2% of the company's shares [7] - Hangyu Technology plans to sell up to 752,800 repurchased shares to supplement working capital [8] Group 5 - Sichuan Electronics expects a net loss of between 265 million to 340 million yuan for the year 2025 [10] - Jinzongzi Wine anticipates a net loss for the 2025 fiscal year, although the loss is expected to narrow compared to the previous year [11] - Hebang Bio forecasts a net loss for 2025 due to anticipated asset impairment provisions [12] Group 6 - Dechang Co. expects a net profit decrease of 51% to 61% for 2025, estimating a profit of 160 million to 200 million yuan [13] - Kosen Technology and Weiyuan Co. both project net losses for 2025 [14][15] - Xiantan Co. reported a chicken product sales revenue of 530 million yuan in December 2025, with a year-on-year increase of 9.41% [16] Group 7 - Shangluo Electronics' application for issuing convertible bonds has been accepted by the Shenzhen Stock Exchange [17] - Zhongheng Group anticipates a net loss for 2025 [18]
本周操盘攻略:市场短期热度有望延续
Wind万得· 2026-01-11 22:42
Market News - China will release December import and export data on January 14, with exports expected to grow by 3.0% year-on-year, down from 5.9% in November, while imports are anticipated to decline by 2.9% [3] - The trade balance for December 2025 will also be published on January 14, with total goods trade from January to November 2025 reaching 41.21 trillion yuan, a year-on-year increase of 3.6% [3] Commodity Futures - The Shanghai Futures Exchange will adjust the price limit for platinum and palladium futures contracts to 16% starting from January 13, 2026, with the trading margin standard set at 18% [4] Energy Outlook - The U.S. Energy Information Administration (EIA) will release its Short-Term Energy Outlook report on January 13, maintaining the WTI crude oil price forecast for 2025 at slightly below $69 per barrel [5] U.S. Economic Data - The U.S. will release December CPI data on January 13, with core CPI expected to rebound significantly, predicted at 0.36% by Morgan Stanley and 0.38% by Bloomberg, both higher than the average of 0.08% in October and November [6] - Key economic indicators including October and November PPI and November retail sales will also be released, with expectations of moderate PPI growth and a 0.7% rebound in retail sales for November [6] Federal Reserve - The Federal Reserve will publish its latest Beige Book on January 14, indicating that government shutdowns and AI applications have weakened the job market, while rising tariffs and healthcare costs have increased business expenses [7] Earnings Season - The earnings season for Q4 2025 will commence this week, with major banks including JPMorgan, Citigroup, and Goldman Sachs set to report [8] Sector Events - The second China eVTOL Innovation Development Conference is scheduled for January 15-16, 2026, in Shanghai, focusing on the new commercial era of eVTOL [10] - The fourth Data Center Liquid Cooling & AI Chip Thermal Management Supply Chain Conference will be held on January 14-15, 2026, in Shenzhen [10] - China's first comprehensive law in the nuclear energy sector, the Atomic Energy Law, will take effect on January 15, 2026 [11] Individual Company News - Hangyu Technology announced on January 11 that it has repurchased 752,800 shares, with plans to sell them within six months [13] - Huadong Medicine's subsidiary has developed a breakthrough treatment for severe hypertriglyceridemia, which has been included in the list of breakthrough therapies by the National Medical Products Administration [13] - Jingfeng Mingyuan plans to acquire 100% of Sichuan Yichong Technology Co., with a key review meeting scheduled for January 16, 2026 [13] - TSMC has commenced research on its next-generation 1.4nm process, with risk trial production expected to start in 2027 [13] Lock-up Expiration - From January 12 to January 16, 2026, 23 companies will have lock-up shares released, totaling 2.434 billion shares with a market value of approximately 48.56 billion yuan [16] - The highest market value of lock-up shares released on January 12 is from Tianxin Pharmaceutical at 7.84 billion yuan [17] New Stock Calendar - Two new stocks are set to be issued this week, with a total issuance of approximately 34 million shares and expected fundraising of 1.909 billion yuan [19] Market Outlook - The current market enthusiasm is driven by concentrated inflows from previously cautious funds, with expectations for continued momentum in thematic and small-cap stocks until after the Two Sessions [22] - Guojin Securities suggests that the spring market is likely to perform well, with a focus on AI investments and the recovery of domestic manufacturing [23] - Everbright Securities anticipates sustained market heat but warns of potential cooling as the Lunar New Year approaches, recommending attention to sectors like electronics and power equipment [24]